Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2778 (LINC02778)

Target
LINC02778
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2778 (LINC02778) is annotated as a lincRNA, which is a subclass of long non-coding RNAs (lncRNAs) characterized by being longer than 200 nucleotides and transcribed from the genome without overlapping protein-coding genes. LincRNAs have been shown to act as regulators of gene expression, often in a tissue- or context-specific manner, by interacting with chromatin, proteins, or other RNAs, although the functions of most individual lincRNAs remain unknown or poorly characterized. Currently, there is no evidence that LINC02778 is a validated therapeutic target, nor are there published biological, clinical, or pharmacological data specific to this molecule. There is no literature linking LINC02778 to specific biological functions, diseases, or drug interactions. The entry appears to be simply an annotated non-coding RNA transcript with no experimentally demonstrated function. This name is not associated with a classical therapeutic target, such as a receptor, enzyme, transporter, or similar druggable entity.

02

Biological functions

Regulation of gene expression (general property of lincRNAs)Modulation of chromatin state (as a property of lincRNAs)Potential role in RNA stabilization and transcription regulation (as a property of lincRNAs)
03

Disease associations

Other (lincRNAs in general are implicated in diverse processes including cancer, but no disease role identified for LINC02778 specifically)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2778 (LINC02778).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2778 (LINC02778).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call